We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
СОВРЕМЕННЫЕ АСПЕКТЫ ЛЕЧЕНИЯ СПАСТИЧЕСКОГО СИНДРОМА ПРИ СПИНАЛЬНЫХ МИЕЛОПАТИЯХ
- Authors
Турсынов, Н. И.; Григолашвили, М. А.; Илюшина, Н. Ю.; Хан, С. С.; Ким, Е. Д.
- Abstract
Spasticity in myelopathies always burdens the course of the disease worsens the prognosis, restrains the ability to self-service and noticeably lowers the life quality while leading to social and psychological maladjustment. Objective. To identify the impact of the botulinum toxin type A application in patients with vertebral myelopathy. Materials. 18 patients with vertebral myelopathy (8 people with cervical lesions, 4 with thoracic lesions and 6 with lumbar-sacral vertebras lesions). Methods of the study. Analysis of the anamnestic data, clinical data of the neurological observation, CT and MRI imaging with inclusion of some other radiological imaging. Results. Positive effect was achieved in the form of reduced hypertonus in muscles and pain, increased ability to self-service, improved walking and rehabilitation measures became more effective. Conclusion. Integrated reasonable treatment with botulinum toxin type A (Dysport) and use of neurorehabilitation activities that increase the functionality of the patient (physical therapy, physical and orthopedic exercises, hydrotherapy and etc.) allows to achieve positive results in spinal myelopathy.
- Subjects
CERVICAL spondylotic myelopathy; SPASTICITY diagnosis; NEUROLOGICAL intensive care; DIAGNOSIS
- Publication
Neurosurgery & Neurology of Kazakhstan, 2016, Vol 43, Issue 2, p24
- ISSN
1813-3908
- Publication type
Article